Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5K Buy
+13,855
New +$33.4K ﹤0.01% 12677
2025
Q1
Sell
-125
Closed -$29.8K 15224
2024
Q4
$29.8K Buy
+125
New +$38.8K ﹤0.01% 12884
2024
Q2
Sell
-18
Closed -$23.2K 15011
2024
Q1
$23.2K Sell
18
-11
-38% -$17.4K ﹤0.01% 12903
2023
Q4
$43.2K Buy
+29
New +$66.5K ﹤0.01% 11935
2023
Q2
Sell
-3
Closed -$12.2K 14927
2023
Q1
$12.2K Sell
3
-20
-87% -$137K ﹤0.01% 13432
2022
Q4
$75.1K Buy
23
+10
+77% +$46K ﹤0.01% 11610
2022
Q3
$66K Buy
13
+6
+86% +$43.2K ﹤0.01% 11425
2022
Q2
$24K Buy
+7
New +$25.9K ﹤0.01% 12324
2022
Q1
Sell
-29
Closed -$344K 14240
2021
Q4
$344K Buy
+29
New +$364K ﹤0.01% 10609
2020
Q1
Sell
-3
Closed -$97K 9969
2019
Q4
$97K Buy
+3
New +$102K ﹤0.01% 8564
2018
Q4
Sell
-2
Closed -$249K 9543
2018
Q3
$249K Hold
2
﹤0.01% 7879
2018
Q2
$214K Hold
2
﹤0.01% 7779
2018
Q1
$225K Sell
2
-3
-60% -$285K ﹤0.01% 7174
2017
Q4
$240K Sell
5
-8
-62% -$500K ﹤0.01% 6815
2017
Q3
$1.22M Buy
+13
New +$1.12M ﹤0.01% 4034

Other funds holding NCNA

Citadel Advisors's NCNA Position: Q1 2026 in Review

Citadel Advisors opened a new position in NuCana (NCNA) in Q1 2026: 13,855 shares worth $19.5K. The stake represents ﹤0.01% of the portfolio and ranks #12677 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NCNA as recently as Q4 2024.

Citadel Advisors first reported a position in NCNA in Q3 2017 and has held it in 15 quarters since. The position peaked at $1.22M in Q3 2017. 8 funds tracked by Wall St. Rank hold NCNA as of Q1 2026.

  • Citadel Advisors held 13,855 shares of NuCana worth $19.5K as of Q1 2026.
  • NuCana was a new Citadel Advisors position in Q1 2026.
  • NuCana made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12677 holding.
  • Citadel Advisors first reported a position in NuCana in Q3 2017 and has held it in 15 quarters since.
  • Citadel Advisors's NuCana position peaked at $1.22M in Q3 2017.
  • 8 funds tracked by Wall St. Rank held NuCana as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.